Detailed Analysis and Radiomic Prediction of First Progression Sites of First-Line Targeted Therapy for EGFR-Mutant Lung Adenocarcinoma Patients With Systemic Metastasis

BACKGROUND: We aimed to analyze the first progression sites of first-line tyrosine kinase inhibitor (TKI) treatment for EGFR-mutant lung adenocarcinoma patients with systemic metastasis to recognize the potential candidates who might benefit from radiotherapy and establish a radiomic-based model to...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoyang, Hou, Runping, Yu, Wen, Zhu, Xueru, Li, Hongwei, Yang, Yidong, Qian, Dong, Fu, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524083/
https://www.ncbi.nlm.nih.gov/pubmed/34676174
http://dx.doi.org/10.3389/fonc.2021.757892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524083/
https://www.ncbi.nlm.nih.gov/pubmed/34676174
http://dx.doi.org/10.3389/fonc.2021.757892

Ejemplares similares